Announced Tue, 19 May · 12:13 IST

Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Meeting of the Board of Directors ....

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
1-day move
₹62.55
prior close
₹62.24
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0+0.7+1.8+3.9+1.5+1.5-3.0+7.8+13.5
Up moveDown movePending
AI summary

Sunil Healthcare Ltd has informed BSE that its Board of Directors meeting is scheduled for May 29, 2026 via video conferencing. The meeting will consider and approve the Audited Financial Results for Q4 FY 2025-26 and the full financial year 2025-26 ended March 31, 2026 (both standalone and consolidated). The company has also confirmed that the Trading Window remains closed from April 1, 2026 till May 31, 2026 under SEBI Insider Trading Regulations. This is a routine quarterly/annual results meeting intimation filed under SEBI LODR Regulations 29 and 33.

Likely market impact

This is a standard board meeting notice for quarterly/annual financial results. The outcome (approval or rejection of results) could impact the stock price once disclosed. The trading window closure prevents insider trading ahead of the results announcement.